Richard's Story
On an April morning in 2007, Richard Catlett, then age 67, got up early to mow his lawn. While walking through the grass, his leg gave out and he collapsed. That was the start of what would become a seven-year battle with cancer.
The cancer had started in his kidney then spread to his bone. Doctors treated him with surgery, radiation, and a targeted therapy called sunitinib (Sutent®). These treatments worked for a while, but eventually the cancer came back—with a vengeance—spreading to his lungs, liver, and lymph nodes.
In October 2013, Richard enrolled in a clinical trial of an immunotherapy called nivolumab, which targets the PD-1 checkpoint, at Seattle Cancer Care Alliance in Washington. Richard’s response to treatment was nothing short of amazing.
A year later, nearly all his tumors have shrunk down to nothing. He is walking and exercising again, tending to his apple trees, and enjoying spending time with his wife, Dianne, and his dog, Chloe.
Richard passed away in September 2020 and is survived by his wife, Dianne, and his sister, Sherri Lewis.
Originally published January 20, 2015.